Scholarlink

<p>A survey was conducted to determine attitudes, knowledge, and educational needs of mental health professionals regarding pharmacogenomics. We recruited 128 clinicians working in mental health in England, and we assessed their experiences using an adapted version of the “U‐PGx Clinician’s Questionnaire”. Responding clinicians had positive attitudes towards pharmacogenomics testing, although they lacked confidence in ordering and interpreting tests, for which most had never received any formal training. Only 6% of clinicians answered all 4 knowledge testing questions correctly, and barriers to clinical implementation included lack of familiarity and knowledge for several pharmacogenomics concepts, such as drug metabolism and genetics, as well as needing support from their working institution. Looking ahead, we found that accredited workshops and patient cases were preferred learning formats, and we suggest tailored education programmes to enable mental health professionals to apply pharmacogenomics in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pharmacogenomics to optimise psychotropic prescribing: a survey of mental health professionals’ perceptions, knowledge, and educational needs

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月20日

查看全文
  • Daniele Panconesi,
  • Stephen Murtough,
  • Marius Cotic,
  • Noushin Saadullah Khani,
  • Lauren Varney,
  • Maria Richards-Brown,
  • Rosemary Abidoph,
  • Daisy Mills,
  • Alvin Richards-Belle,
  • Jazmin Molai,
  • James Fenwick,
  • Joanna Curwen,
  • Matthew Allin,
  • Alex Berry,
  • Magdalana Barczyk,
  • Stefania Bonaccorso,
  • Rebecca Griffiths,
  • Massimo Bernini,
  • Ajai Kumar,
  • Suruthy Senthilkumar,
  • Yogita Dawda,
  • Rajvinder Shokkar,
  • Rosie Murdoch,
  • Jamie Crane,
  • Yousuf Rahimi,
  • Myles Howard,
  • Alison Welfare-Wilson,
  • Agostina Secchi,
  • Carmel Thomas,
  • Bethany Pastor,
  • Parveen Sharma,
  • Georgy Pius,
  • Rashad Nazir,
  • Asif Mir,
  • Jack Cheshire,
  • Rhianne Bostock,
  • Simon Gibbon,
  • Pratima Singh,
  • Chetan Shah,
  • Sabrina Richards,
  • Sai-Bo Cheung,
  • Louise Rowe-Leete,
  • Anita Jibero,
  • Rebecca Cox,
  • Philip Van Driel,
  • Elvira Bramon

摘要

A survey was conducted to determine attitudes, knowledge, and educational needs of mental health professionals regarding pharmacogenomics. We recruited 128 clinicians working in mental health in England, and we assessed their experiences using an adapted version of the “U‐PGx Clinician’s Questionnaire”. Responding clinicians had positive attitudes towards pharmacogenomics testing, although they lacked confidence in ordering and interpreting tests, for which most had never received any formal training. Only 6% of clinicians answered all 4 knowledge testing questions correctly, and barriers to clinical implementation included lack of familiarity and knowledge for several pharmacogenomics concepts, such as drug metabolism and genetics, as well as needing support from their working institution. Looking ahead, we found that accredited workshops and patient cases were preferred learning formats, and we suggest tailored education programmes to enable mental health professionals to apply pharmacogenomics in clinical practice.